Disruption of Metabolic Pathways - Perspectives for the Treatment of Cancer

Author(s): Eliana P. Araujo, Jose B. Carvalheira, Licio A. Velloso.

Journal Name: Current Cancer Drug Targets

Volume 6 , Issue 1 , 2006

Become EABM
Become Reviewer

Abstract:

Several growth-promoting signaling pathways have tight molecular connections with metabolicrelated signal transduction systems. By controlling these pathways, cancer cells gain autonomy over energyacquiring systems and, thus, expand their potential for proliferation. Here, we discuss the use of drug and antisense oligonucleotide approaches to inhibit metabolic pathways in cancer cells and their potential use in the therapeutics of cancer.

Keywords: protein kinase B, protein remodeling, Akt Activation, phosphotyrosine binding (PTB), CCI-779, Antisense oligonucleotides

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 6
ISSUE: 1
Year: 2006
Page: [77 - 87]
Pages: 11
DOI: 10.2174/156800906775471734

Article Metrics

PDF: 14